We maintain Sell on Tata Chemicals Ltd (TTCH) based on our revised target price (TP) of Rs253 post the 2QFY21 results concall. We still remain cautious on the outlook for the core chemicals business. Global consultant IHS Markit expects pressure on demand and pricing to persist until the end of CY21 and expects a recovery by CY22. We retain our estimates, but raise the TP by 9% on account of changes in the value of Rallis India and add other non-current holdings in group companies. The management expects volume in the troubled soda ash business (around 75% of revenue) to recover gradually over the next 6 months, while adding that this hinges on the current recovery in all segments, barring realty, which accounts for 32% of the global soda...

Tata Chemicals' (TTCH) operating performance was muted across geographies (barring Europe). This was primarily led by North America and India, where EBITDA declined 48% and 40% respectively. The Soda Ash segment's performance was impacted by reduction in demand from the end user industry (largely for flat and container glass). Factoring in the miss to our estimates (due to one-time cost) and weak end-user industry demand scenario, we cut our EBITDA estimates by 6% for FY21 while...

North America (NA) mainly caters to Latin America and South East Asia in terms of exports market. The NA region recorded export sales volume fall of 33% YoY to 197,000 MT. The management believes that subdued exports sales volumes were partly was on account of higher Covid-19 cases in Brazil, which impacted production value chain across end user industries and thereby pressurised demand for soda ash. Further, lower construction activity in southern Asian countries along with increase in supply from China depressed realisations for soda ash. Hence, this impacted the performance...

Pressure on earnings from hit on soda ash volumes to persist We maintain Sell on Tata Chemicals Ltd (TTCH) based on our revised earnings and Target Price of Rs232 post the 1Q results concall. We have cut earnings 33.1%/11.6% over FY21/FY22E, but raised the TP 7.5%, based on a 10% increase in our Target EV/E (our new estimates represent trough volumes/margins for chemicals), and the increase in the value of its stake in Rallis India. Management expects volumes in the troubled soda ash business (around 75% of revenue) to recover gradually over the next 6-9 months, while adding that this hinges on a recovery in the auto/realty segments, which accounted for 32% of global soda ash demand. There are signs of...

Flat glass demand likely to improve by end of this fiscal Due to lockdown, there was a slowdown in construction activity primarily due to labour/demand related issues. Further, there was a slowdown in auto activity also, impacting demand for flat glass and, thereby, soda ash consumption. Flat glass is estimated to comprise ~50% of soda ash demand. The management believes flat glass demand would improve by end of this fiscal and can support better demand growth from next year. Further, majority of the new capacity from China, North America has been...

This was primarily led by North America (NA), wherein EBITDA declined 81% YoY on lower volume offtake. The Soda Ash segments performance was impacted by a reduction in demand from the end user industry (largely for flat and container glass). Factoring the miss in our estimates and a weak end user industry demand scenario, we cut our EBITDA estimates by 14%/6% for FY21/FY22 and arrive at an SOTP-based TP of INR368. Maintain was primarily on account of the absence of operating leverage and higher RM cost, offset by lower freight and power costs. EBITDA de-grew 30% YoY INR1,824m); decline in adj. This was on account of a 28%/22% drop in soda ash/bicarb volumes and lower realization, offset by 26% volume growth in salt. revenue declined 27% YoY due to a 28% drop in volumes (exports / domestic volumes declined 45% / 13% YoY).

25 July 2020 TTCH India Soda Ash business reported revenue decline of 10% to INR14.8b, primarily due to significant 9% drop in volumes (to 634kMT) and 1% decline in realizations. This was due to an oversupplied market (incl. increased imports) and decline in Soda Ash prices. Tata Chemicals North America (TCNA) revenues declined marginally by 0.3% YoY to USD480m in FY20, mainly due to 1% drop in realizations (to USD215/MT). However, this was offset by marginal 0.6% increase in sales volume (to 2.23MMT). TCNA revenue (in INR terms) inched up 1% YoY to INR34b while EBITDA increased 8.5% YoY to INR7.4b. Its Europe operations reported ~5% YoY revenue decline to GBP150m in FY20, which was mainly due to the 11% YoY fall in Soda Ash volumes (to 0.29MMT). However, this was partially offset by 1% YoY increase in Bicarbonate volumes (to 0.

Given the improving capacity utilization across plants, and strong performance of Specialty products, we expect PAT to grow at CAGR of 13.7% over FY20-22E, led by a steady growth in revenue and improved margins. We upgrade our rating to ACCUMULATE on the stock with a...

Capex programme altered until demand outlook improves The company announced capex of around | 2400 crore last year to increase capacity for soda ash, soda bicarbonate, cement and salt by FY22-23E. It was about to spend | 900 crore this fiscal, part of the announced capex, which is expected to reduce due to demand challenges post Covid-19. The company would announce the altered capex schedule post Q1FY21E. Revise our rating from REDUCE to...

Downgrade to Sell on growth and valuation concerns post recent rally Sell We are downgrading Tata Chemicals Ltd (TTCH) from Accumulate to Sell based on our recently reduced TP of Rs216 post the 4Q results concall, which suggested that its core chemicals business is likely to take 18-24 months to achieve normalcy in demand and supply. The company however remains hopeful that the disruption in the chemical supply chain due to COVID-19 itself may gradually abate with the easing trend in lockdown across key countries, including China, which controls more than 40% of global soda ash demand. The 4QFY20 consolidated results was a miss with PAT coming in at Rs1.84bn vs our/consensus estimates at...

We are downgrading TTCH (now ex-consumer) from Buy to Accumulate with our reduced TP of Rs220 (-3.8% from CMP) post our aggressive cuts in FY20-22E. We have cut our earnings for FY20E by 13.2% on the marginal impact of the lockdown in March. We have cut our FY21-22E volume, price and margin estimates in Chemicals across all its geographies due to (a) the immediate lockdown impact due to reduction in all its operations, according to the company's recent exchange filing (Annexure - II) and (b) the risk of global demand destruction in key end use segments for its key product soda ash (75% of revenue) of at least 10% on average over the year due to the collapse in the global economy, particularly in key markets in the US and EU....

In our midcap universe of 11 companies, we expect Tata Chemical, VA Tech Wabag, Emmbi Industries and Kanpur Plastipack to be the most impacted stocks given that all these have revenue contribution in excess of 30-35% from the said geographies. We have envisaged the impact of Coronavirus (Covid-19) on our midcap coverage universe based on the revenue contribution from both the US as...

We value the domestic soda ash business at 5x FY21E EV/EBITDA and overseas at 4x EV/EBITDA. We arrive at a target price of | 360, excluding investment portfolio value, providing an upside of 14% over CMP of | 316....

TCL ventured into the silica, nutraceutical business with a capex of ~| 500 crore. The same is expected to generate asset turn of 1.5-2x, RoCE of ~1520%, which we expect to improve return ratio profile for the overall group in the medium to long run. Apart from this, strong growth visibility from cathode active material and Tata Chemical's position in the entire chemistry would put the company in a favourable position in the long run. All this, in...

Tata Chemicals' (TTCH) 3QFY20 consolidated results were reported for the continuing operations - i.e excluding the consumer business being demerged in favour of TGBL post the NCLT's approval for this transfer. We are maintaining our earnings model and valuations including the consumer business - pending the official transfer. We maintain BUY on our revised SOTP-based TP of 897 - post changes in our estimates that imply ex-consumer valuation of Rs462. The results (on ex-consumer basis) were a tad below expectation. Revenue was up 2% at Rs26.2bn the 40% growth in specialty (read Rallis) offset the 6% fall in basic chemistry segment. EBITDA margin came in 190 bps below expectations, with a 9% miss at EBIT level. The EBIT growth was driven by CPC subsidiary Rallis under specialty segment. The interest expense...

Crop protection chemicals and fertilizer cos. should see healthy demand and margins in 3QFY20E. The extended kharif and early sowing trends in Rabi supported by all time high reservoir levels augur well for UPL and CRIN. Tata Chemicals should be a steady performer with India seeing an uptick in chemical volume, along with an improved outlook for UK operations. Post the minority stake buyout in its US business, we expect TTCH to benefit from the additional 25% share of TCNA PAT that will be earnings accretive, effective this quarter. UPL: LatAm and India along with Arysta portfolio are likely to be in focus. We see good...

The Tata Chemicals (TTCH) management has guided for long term growth and improvement Sector: Chemicals in returns based on ongoing investments and new initiatives in Energy storage at the analyst meet on Monday. The latter includes Lithium battery project still on the drawing board stage, CMP: Rs664 pending tie up with JV partner. Management is reasonably positive on Soda Ash market over the next 12 months based on nil capacity addition and 4-5% growth in emerging markets Target Price: Rs798 (EM), including India. The company is stressing on its growth plans for Bicarb, which enjoys higher margins and growth prospects, especially in the Pharma segment, and flue gas Upside: 20.1% treatment. The company expects the ongoing new investments in Nutraceuticals, Silica and...

20 December 2019 Tata Chemicals (TTCH) has acquired the remaining 25% stake in TATA Chemicals Soda Ash Partners Holdings (TCSAP) from the Andover Group, Inc. for USD195m (thus, valuing 100% stake at USD780m) through its wholly-owned subsidiary, Valley Holdings Inc. With this acquisition, TTCH has increased its ownership in TCSAP to 100%, which is a move to simplify enterprise architecture. For FY19, TCSAP had a turnover of USD466m and EBITDA of USD101m. TTCH currently operates a capacity of 2.5MMT of natural soda ash in North America. The worlds largest deposits of trona used for manufacturing natural soda ash are found in the Green River Basin of Wyoming, North America. TTCH acquired the balance 25% stake in TCSAP for USD195m; of this, USD175m will be funded through debt and balance will be funded internally.

At the time of the announcement, the deal valued the Consumer business at ~18x FY19 EBITDA, implying an EV of INR57.6b (INR226/share). As a result, the value/share of the consumer business being transferred to TGBL stands at INR342/share. Against this backdrop, we attempt to analyze the valuation at which the residual business is available. We back calculated the valuations at which the residual business is available factoring in the current market prices. According to our calculations, the enterprise value post demerger adjusts for the value of Rallis, quoted investments and value of TGBLs shares to be received by the shareholders of TTCH. We also adjusted EBITDA post the demerger of the Consumer business and Rallis (we have excluded Rallis EBITDA as we have done the same in our EV calculation). Thus, the residual business is available at 4.4x/3.7x FY20/21E EV/EBITDA.

31 October 2019 higher depreciation and lower other income. PAT was up 10% 1HFY20, revenue/EBITDA/PAT were up 5%/12%/7% YoY. Chemistry EBIT margin expanded strongly by 670bp YoY to 29.8% in the quarter. However, Consumer margin shrank 450bp YoY due to one-time demerger-related cost and higher ad spends. In 9% YoY, led by volume growth of 3% and the balance through realization improvement. EBITDA/MT increased 2x YoY to USD52 in the quarter on the back of improved efficiencies, lower input cost and reduced fixed cost. sales declined 5% YoY due to lower trading volumes, but EBITDA was up 36% YoY led by lower manufacturing cost (RM and energy). EBITDA/MT increased 48% YoY to GBP49. In the EBITDA/MT improved 6% YoY to USD47 (-7% QoQ) with realizations remaining flat YoY (-1% QoQ) and sales volume growth of 1% YoY. We largely maintain our estimates of revenue/EBITDA/PAT CAGR of 9%/15%/11% over FY19-21.